Pharmaceuticals in Belgium

"Datamonitor’s Pharmaceuticals in Belgium industry profile is an essential resource for top-level data and analysis covering the pharmaceuticals industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.

Scope

* Contains an executive summary and data on value, volume and/or segmentation

* Provides textual analysis of the industry’s recent performance and future prospects

* Incorporates in-depth five forces competitive environment analysis and scorecards

* Includes a five-year forecast of the industry

* The leading companies are profiled with supporting key financial metrics

* Supported by the key macroeconomic and demographic data affecting the market

Highlights

* Detailed information is included on market size, measured by value and/or volume

* Five forces scorecards provide an accessible yet in depth view of the market’s competitive landscape

* Market shares are covered by manufacturer or brand

Why you should buy this report

* Spot future trends and developments

* Inform your business decisions

* Add weight to presentations and marketing materials

* Save time carrying out entry-level research

Market Definition

The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2006 annual average exchange rates.

For the purpose of this report Europe comprises Belgium, the Czech Republic, Denmark, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden and the UK.

Table of Contents
TABLE OF CONTENTS
EXECUTIVE SUMMARY 3
CHAPTER 1 Market Overview 7
1.1 Market Definition 7
1.2 Research Highlights 7
1.3 Market Analysis 8
CHAPTER 2 Market Value 9
CHAPTER 3 Market Segmentation I 10
CHAPTER 4 Market Segmentation II 11
CHAPTER 5 Market Share 12
CHAPTER 6 Five Forces Analysis 13
6.1 Summary 13
6.2 Buyer Power 14
6.3 Supplier Power 15
6.4 New Entrants 17
6.5 Substitutes 18
6.6 Rivalry 19



CHAPTER 7 Leading Companies 20
7.1 Pfizer Inc 20
7.2 Sanofi-Aventis 23
7.3 GlaxoSmithKline Plc 25
7.4 AstraZeneca Plc 29
CHAPTER 8 Market Forecasts 32
8.1 Market Value Forecast 32
CHAPTER 9 Macroeconomic Indicators 33
CHAPTER 10 Appendix 35
10.1 Methodology 35
10.2 Industry Associations 36
10.3 Related Datamonitor Research 36

LIST OF TABLES
Table 1: Belgium Pharmaceuticals Market Value: $ million, 2003-2007 9
Table 2: Belgium Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 10
Table 3: Belgium Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 11
Table 4: Belgium Pharmaceuticals Market Share: % Share, by Value, 2007 12
Table 5: Key Facts: Pfizer Inc 20
Table 6: Key Financials: Pfizer Inc 22
Table 7: Key Facts: Sanofi-Aventis 23
Table 8: Key Financials: Sanofi-Aventis 24
Table 9: Key Facts: GlaxoSmithKline Plc 25
Table 10: Key Financials: GlaxoSmithKline Plc 28
Table 11: Key Facts: AstraZeneca Plc 29
Table 12: Key Financials: AstraZeneca Plc 31
Table 13: Belgium Pharmaceuticals Market Value Forecast: $ million, 2007-2012 32
Table 14: Belgium Size of Population (million) , 2003-2007 33
Table 15: Belgium GDP (Constant 2000 Prices, $ billion), 2003-2007 33
Table 16: Belgium Inflation, 2003-2007 33
Table 17: Belgium Exchange Rate, 2003-2007 34

"